0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bioequivalence"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$2,975USDGBP
EUR$3,500USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$2,975USDGBP
EUR$3,500USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
From
EUR$4,150USDGBP
Asia Pacific Biosimulation Market Report and Forecast 2024-2032 - Product Thumbnail Image

Asia Pacific Biosimulation Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Asia Pacific
From
EUR$3,869USDGBP
EUR$279USDGBP
EUR$249USDGBP
Loading Indicator

Bioequivalence is a term used in biotechnology to describe the similarity between two pharmaceutical products. It is used to assess the interchangeability of two products, such as generic and brand-name drugs, and to ensure that they have the same therapeutic effect. Bioequivalence studies are conducted to compare the pharmacokinetic properties of two products, such as their absorption, distribution, metabolism, and excretion. The results of these studies are used to determine whether the two products are therapeutically equivalent and can be used interchangeably. The bioequivalence market is a rapidly growing sector of the biotechnology industry. It is driven by the increasing demand for generic drugs, as well as the need for regulatory compliance. Companies in this market provide services such as bioequivalence studies, pharmacokinetic analysis, and regulatory consulting. Some companies in the bioequivalence market include Parexel, Covance, Quintiles, and PPD. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more